‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address
In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science
Latest Statistics Show Decline In Deaths From Breast Cancer
“What Is Good For NCI Is Good For NIH,” Broder Says In Address
Proposed Deal Could Resolve Key Disputes At NSABP, Pitt
NIH Reconsiders Closing A Meeting Of Advisory Group
NIH Extramural Office Lists Initiatives For Reinvention
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









